Neurology:具有视觉先兆的偏头痛是房颤的危险因素

2018-11-15 xing.T MedSci原创

由此可见,具有视觉先兆的偏头痛与事件性AF的风险增加有关。这可能潜在促进缺血性卒中。

具有视觉先兆的偏头痛与心源性卒中风险相关。近日,神经病学领域权威取杂志Neurology上发表了一篇研究文章,这项社区动脉粥样硬化风险研究的目的是评估具有视觉先兆的偏头痛与房颤(AF)之间的关联。

社区动脉粥样硬化风险研究是一项纵向的、以社区为基础的队列研究,参与者在1993年至1995年期间接受了偏头痛病史的访谈,并在2013年之前进行AF事件随访。研究人员使用心电图、出院诊断代码和死亡证明对AF进行了裁决。与无头痛的对照者相比,多变量Cox比例风险模型用于研究偏头痛及其亚型与事件性AF之间的关系。进行调解分析以评估AF是否是具有视觉先兆偏头痛相关卒中风险的介导因素。

在11939名评估了头痛和既往无房颤或卒中的参与者中,426名患者报告有视觉先兆的偏头痛,1090名患者无视觉先兆的偏头痛,1018名非偏头痛患者和9405名无头痛患者。在20年的随访期内,1516例偏头痛患者中232名(15%)患者以及9405例无头痛患者中1623名(17%)参与者发生了AF。调整多个混杂因素后,与无头痛参与者相比,具有视觉先兆的偏头痛与AF风险增加相关(风险比为1.30,95%置信区间为1.03-1.62),当与无视觉先兆的偏头痛参与者相比,也是如此(风险比为1.39,95%置信区间为1.05-1.83)。数据表明AF可能是具有视觉先兆偏头痛相关卒中风险的潜在介导因素。

由此可见,具有视觉先兆的偏头痛与事件性AF的风险增加有关。这可能潜在促进缺血性卒中。

原始出处:

Souvik Sen, X, et al.Migraine with visual aura a risk factor for incident atrial fibrillation A cohort study.Neurology. 2018.http://n.neurology.org/content/early/2018/11/14/WNL.0000000000006650

本文系梅斯医学(MedSci)原创编译整理,转载需授权!

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (3)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2000634, encodeId=bdff200063458, content=<a href='/topic/show?id=d5df12695e6' target=_blank style='color:#2F92EE;'>#Neurol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=18, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12695, encryptionId=d5df12695e6, topicName=Neurol)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8217292, createdName=yinhl1978, createdTime=Tue Jun 18 01:32:00 CST 2019, time=2019-06-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1481115, encodeId=9ab61481115a6, content=<a href='/topic/show?id=c592908329c' target=_blank style='color:#2F92EE;'>#视觉#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=90832, encryptionId=c592908329c, topicName=视觉)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=adcf7732830, createdName=zywlvao, createdTime=Sat Nov 17 10:32:00 CST 2018, time=2018-11-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=352690, encodeId=27a235269070, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=82311653708, createdName=医者仁心5538, createdTime=Thu Nov 15 20:31:33 CST 2018, time=2018-11-15, status=1, ipAttribution=)]
    2019-06-18 yinhl1978
  2. [GetPortalCommentsPageByObjectIdResponse(id=2000634, encodeId=bdff200063458, content=<a href='/topic/show?id=d5df12695e6' target=_blank style='color:#2F92EE;'>#Neurol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=18, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12695, encryptionId=d5df12695e6, topicName=Neurol)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8217292, createdName=yinhl1978, createdTime=Tue Jun 18 01:32:00 CST 2019, time=2019-06-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1481115, encodeId=9ab61481115a6, content=<a href='/topic/show?id=c592908329c' target=_blank style='color:#2F92EE;'>#视觉#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=90832, encryptionId=c592908329c, topicName=视觉)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=adcf7732830, createdName=zywlvao, createdTime=Sat Nov 17 10:32:00 CST 2018, time=2018-11-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=352690, encodeId=27a235269070, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=82311653708, createdName=医者仁心5538, createdTime=Thu Nov 15 20:31:33 CST 2018, time=2018-11-15, status=1, ipAttribution=)]
    2018-11-17 zywlvao
  3. [GetPortalCommentsPageByObjectIdResponse(id=2000634, encodeId=bdff200063458, content=<a href='/topic/show?id=d5df12695e6' target=_blank style='color:#2F92EE;'>#Neurol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=18, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12695, encryptionId=d5df12695e6, topicName=Neurol)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8217292, createdName=yinhl1978, createdTime=Tue Jun 18 01:32:00 CST 2019, time=2019-06-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1481115, encodeId=9ab61481115a6, content=<a href='/topic/show?id=c592908329c' target=_blank style='color:#2F92EE;'>#视觉#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=90832, encryptionId=c592908329c, topicName=视觉)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=adcf7732830, createdName=zywlvao, createdTime=Sat Nov 17 10:32:00 CST 2018, time=2018-11-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=352690, encodeId=27a235269070, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=82311653708, createdName=医者仁心5538, createdTime=Thu Nov 15 20:31:33 CST 2018, time=2018-11-15, status=1, ipAttribution=)]
    2018-11-15 医者仁心5538

    学习了

    0